Total Brain Limited (Ticker: TTBLF) is a global leader in the development and provision of comprehensive brain health solutions. The company manufactures and delivers a range of digital therapeutic products and services including cognitive assessment tools; personalized brain training programs; mental health insights and analytics; and neurofeedback technologies. Its flagship platform integrates neuropsychological assessments with digital interventions to support mental wellness, cognitive performance enhancement, and behavioral health management. Total Brain primarily serves healthcare providers, employers, insurers, and individual consumers across markets in North America, Europe, and Asia. Founded in 2014 and headquartered in the United States, Total Brain focuses on leveraging advanced data science and AI to deliver actionable brain health insights at scale.
In the last 1-2 years, Total Brain Limited has expanded its product offerings by launching new digital brain health monitoring and personalized therapy solutions. The company has also forged strategic partnerships with health systems and corporate wellness programs aimed at integrating its cognitive assessment and training technologies into broader healthcare and employee wellness frameworks. These initiatives underscore Total Brain's commitment to scaling its impact through both direct-to-consumer and institutional channels. The company has not undergone any major rebranding or name changes recently but has significantly enhanced its operational footprint and technological capabilities to address rising global mental health needs. Total Brain remains a pioneer in the intersection of neuroscience, digital health, and AI-driven behavioral interventions.